Recent Advances in Understanding and Managing Cardiomyopathy [version 1; referees: 2 approved]

Abstract

Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease. Currently, cardiomyopathy is the leading diagnosis of heart transplant patients worldwide. Incorporation of next-generation sequencing strategies will likely revolutionize genetic testing in cardiomyopathy. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing has opened a new avenue for precision medicine in cardiomyopathy. Stem cell therapy, gene therapy, interfering RNA, and small molecules are actively being evaluated in clinical trials.

Keywords

• Arrhythmias, Electrophysiology & Pacing
• Cardiovascular Imaging
• Cardiovascular Pharmacology
• Congenital Heart Disease
• Geriatric Cardiology
• Heart Failure
• Medical Genetics
• Valvular Disease